FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

EUPRAXIA PHARMACEUTICALS INC.: net_income

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/519917e6-0b87-4389-bb1a-aae8e05315c4

Reported value

$-18.490M{"amount": -18489629, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Entity
EUPRAXIA PHARMACEUTICALS INC.
Metric
net_income
Period
2022-01-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-24-083584 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:08:11.955526+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001581178/net-income/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.